Ciência, tecnologia e produção no Butantan
DOI:
https://doi.org/10.11606/issn.2316-9036.v0i89p78-89Keywords:
Butantan Institute, vaccines, technologyAbstract
The Butantan Institute (IB) is a São Paulo state public institution over a hundred years old. The scientific works produced by researchers at IB, as well as the international visibility of their results, have grown considerably in the last decade. The vaccines and hyperimmune serums produced at IB by means of its own techno-logy, which make up most of the products of this kind used in Brazil, have been object of scientific publications by IB researchers. The system which encompasses the Butantan Institute and the Butantan Foundation make up a one-of-a-kind institution in which basic research, technological development and production are gathered in one single space. That provides Brazil with immunobiologicals at the frontier where state-of-the-art knowledge and technology meet.Downloads
References
ANDRADE, P. M. e col. “The Therapeutic Potential of Recombinant BCG Expressing the Antigen S1PT in the Intravesical Treatment of Bladder Cancer“, in Urologic Oncology-Seminars and Original Investigations, 28(5), 2010, pp. 520-5.
CAMARGO, Erney Plessmann; SANT’ANNA, Oswaldo Augusto. “Institutos de Pesquisa em Saúde”, in Ciência & Saúde Coletiva, 9(2), 2004, pp. 295-302.
CARNIEL, E. F. e col. “Immunogenicity and Safety of Combined Intradermal Recombinant Hepatitis B with BCG Vaccines at Birth“, in Vaccine, 26(5), 2008, pp. 647-52.
CHAIMOVICH, Hernán. Entrevista ao Estado de S. Paulo, 27/6/2010.
DAVIES, Gwyn (ed.). “Vaccine Adjuvants”, in Humana Press. Nova York, 2010.
DE ALMEIDA, Marta. “São Paulo na Virada do Século XX: um Laboratório de Saúde Pública para o Brasil”, in Tempo, no
, Rio de Janeiro, 2005, pp. 77-89.
GAD, Shayne Cox (ed.). Clinical Trials Handbook. Hoboken, John Wiley& Sons Inc., 2009.
GRAZZIOLI, Airton; RAFAEL, Edson José. Fundações Privadas: Doutrina e Prática. 2a ed., São Paulo, Atlas, 2010.
GUIDOLIN, R. e col. “Polyvalent Horse F(Ab`)2 Snake Antivenom: Development of Process to Produce Polyvalent HorseF(Ab`)2 Antibodies Anti-african Snake Venom”, in African Journal of Biotechnology, 9, 2010, pp. 2.446-55.
LEÃO, L. I.; HO, P. L.; JUNQUEIRA DE AZEVEDO, I. D. M. “Transcriptomic Basis for an Antiserum Against Micrurus Corallinus (Coral Snake) Venom“, in BMC Genomics 10, Article Number: 112: Mar 16 2009.
MOREL, Regina Lúcia de Moraes. Ciência e Estado, a Política Científica no Brasil. São Paulo, T. A. Queiroz, 1979.
NASCIMENTO, I. P. e col. “Construction of an Unmarked Recombinant BCG Expressing a Pertussis Antigen by Auxotrophic Complementation: Protection Against Bordetella Pertussis Challenge in Neonates“, in Vaccine, 27(52), 2009, pp. 7.346-51.
QUINTILHO, W. e col. “Bordetella Pertussis Monophosphoryl Lipid A as Adjuvant for Inactivated Split Virion Influenza Vaccine in Mice”, in Vaccine, 27(31), 2009, pp. 4.219-24.
RAW, Isaias; HIGASHI, Hisako G. “Autossuficiência e Inovação na Produção de Vacinas e Saúde Pública”, in Estud. Av., vol. 22, no 64, 2008.
TAKAGI, M. e col. “Purification of Capsular Polysaccharide Produced by Haemophilus Influenzae Type B Through a Simple, Efficient and Suitable Method For Scale-up“, in J. of Ind. Microbiol. & Biotechnol., 35(11), 2008, pp. 1.217-22.
TEIXEIRA, L. A.; DE ALMEIDA, M. “Os Primórdios da Vacina Antivariólica em São Paulo: uma História Pouco Conhecida”, in História, Ciências, Saúde, vol. 10, Manguinhos, 2003, pp. 475-98.
WILLIAMS, D. e col. “Global Snake Bite Initiative Working Group; International Society on Toxinology. ‘The Global Snake Bite Initiative: an Antidote for Snake Bite’”, in Lancet, 2; 375(9.708), 2010, pp. 89-91.
ZORZETO, T. Q. e col. “Immunogenicity of Whole-cell Pertussis with Low LPS Lipopolysacaride Content in Infants”, in Clin. Vac. Immunol., 16, 2009, pp. 544-50
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista USP
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
|
Pertence à revista. Uma vez publicado o artigo, os direitos passam a ser da revista, sendo proibida a reprodução e a inclusão de trechos sem a permissão do editor. |
